Larvol Delta - Study-of-CBL0137-in-Combination-With-Ipilimumab-and-Nivolumab-Therapy-in-Melanoma

Yervoy (ipilimumab) - Ono Pharma, BMS

CBL137 IV - Incuron

Opdivo (nivolumab) - Ono Pharma, BMS

http://clinicaltrials.gov/ct2/show/NCT05498792

Aug 12, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next